Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
May 30, 2017
Patent Application Number
14891491
Date Filed
May 30, 2014
Patent Citations Received
Patent Primary Examiner
Patent abstract
The invention provides anti-oncostatin M receptor-β (OSMR) antigen binding proteins. e.g., antibodies and functional fragments, derivatives, muteins, and variants thereof. OSMR antigen binding proteins interfere with binding of OSM and/or IL-31 to OSMR. In some embodiments, anti-OSMR antigen binding proteins are useful tools in studying diseases and disorders associated with OSMR and are particularly useful in methods of treating diseases and disorders associated with OSMR and binding of OSM and/or IL-31 to OSMR.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
